Physician profile
Ann E Tilley
NPI 1972720142
$11,167.93
in general payments reported to CMS, 2019-2025
24 companies · $2,912 in 2025
The $2,912 reported for 2025 was more than what 82% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $442 · 2020: $353 · 2021: $896 · 2022: $1,749 · 2023: $2,307 · 2024: $2,509 · 2025: $2,912.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,566 · Education: $162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,566.13 |
| Education | $161.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,793.62 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $2,043.13 | 2021-2025 | Fasenra, Tezspire, Airsupra |
| Regeneron Healthcare Solutions, INC. | $1,170.00 | 2021-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,102.30 | 2021-2025 | Ofev, Stiolto Respimat, Jascayd |
| Genzyme Corporation | $983.02 | 2021-2025 | |
| Insmed, INC. | $716.28 | 2019-2025 | Arikayce, Brinsupri |
| Mallinckrodt Hospital Products INC. | $527.44 | 2021-2025 | Acthar |
| Amgen INC. | $379.17 | 2021-2024 | Tezspire |
| Baxter Healthcare | $377.68 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Mylan Specialty L.P. | $231.24 | 2022-2024 | Yupelri |
| Verona Pharma, INC. | $198.82 | 2025 | Ohtuvayre |
| Novartis Pharmaceuticals Corporation | $160.59 | 2019-2025 | |
| Paratek Pharmaceuticals, INC. | $89.52 | 2024 | Nuzyra |
| Ani Pharmaceuticals, INC. | $81.93 | 2025 | Purified Cortrophin Gel |
| Viatris Specialty LLC | $72.54 | 2025 | Yupelri |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $42.72 | 2022 | |
| Electromed, INC. | $40.31 | 2023 | Smartvest |
| Takeda Pharmaceuticals U.S.A., INC. | $33.05 | 2025 | Glassia |
| Pfizer INC. | $25.83 | 2025 | |
| Merck Sharp & Dohme LLC | $25.40 | 2020 | |
| Janssen Pharmaceuticals, INC | $22.17 | 2024 | Xarelto |
| Advanced Respiratory, INC | $17.93 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $17.36 | 2025 | Opsumit, Uptravi |
| Novo Nordisk INC | $15.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Tilley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.